APTO
Aptose Biosciences (APTO)
$
18About Aptose Biosciences (APTO)
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Details
Daily high
$0.18
Daily low
$0.18
Price at open
$0.18
52 Week High
$2.16
52 Week Low
$0.13
Market cap
10.7M
Dividend yield
0.00%
Volume
328,588
Avg. volume
466,144
P/E ratio
-.06
Aptose Biosciences News
Details
Daily high
$0.18
Daily low
$0.18
Price at open
$0.18
52 Week High
$2.16
52 Week Low
$0.13
Market cap
10.7M
Dividend yield
0.00%
Volume
328,588
Avg. volume
466,144
P/E ratio
-.06